Ro
The health tech company teamed up with New York State's Department of Public Health to distribute the vaccines.
Reuters' reports also highlighted Sharecare's now confirmed acquisition of healthcare AI startup, doc.ai.
Direct-to-consumer virtual health company Ro announced Monday it’s $200 million Series C funding round.
Also: Kore and Dexcom prepare the G6 CGM for remote patient-monitoring; Tyto Care tackles Europe with santé24 integration and deployment.
Customers will now be able to use the services to get eczema treatment, as well as prescription antiperspirant and dandruff shampoo.
The new medications are focused on seasonal allergies.
The new site contains information about sexual health, hair loss, weight management, diabetes, and men's health.
Now consumers are turning to the web for their health products—whether it is to get a pharmacy prescription, a urine test or an “embarrassing” sexual health product.
Also: Family support coaching app raises $27.5 million; Key components of a dementia care robot.
Previously focused on erecticle dysfunction, Ro is using its latest funding to work on a multipronged smoking cessation platform.